Burden in Colombia of COVID-19 in Adults and the Associated Clinical Characteristics: A Retrospective Database Analysis
Authors:
- Jair ArciniegasJAJair Arciniegas
- Juan Manuel ReyesJRJuan Manuel Reyes
- Jhon Bolaños-LópezJBJhon Bolaños-López
- Julia Regazzini SpinardiJSJulia Regazzini Spinardi
- Jingyan YangJYJingyan Yang
- Farzaneh MalekiFMFarzaneh Maleki
- Farley Johanna GonzalezFGFarley Johanna Gonzalez
- Carlos Jose BelloCBCarlos Jose Bello
- Ana Catalina Herrera-DíazAHAna Catalina Herrera-Díaz
- Omar EscobarOEOmar Escobar
- Andrea RubioARAndrea Rubio
- Monica GarciaMGMonica Garcia
Open Access
- 22 May 2025
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (6) , 146
Abstract
Studies on the burden of COVID-19 cases in Colombia have focused on specific populations and short timeframes. A retrospective observational study was conducted on adult patients aged 18 diagnosed with COVID-19 who received inpatient and/or outpatient medical care at a large health maintenance organization, to evaluate the burden of COVID-19 cases in Colombia (from March 2020 to January 2023) and associations with demographic and clinical characteristics. COVID-19 cases were identified with ICD-10 codes and confirmed by a laboratory test. The statistical analysis focused on descriptors of the frequency of events. A multivariate regression model was used to identify factors associated with severe conditions and death. Of the 953,661 cases detected, most cases (~79%) were mild or moderate (handled as outpatients). There were 20.1% (N = 191,260) severe cases and 0.9% (N = 8841) critical cases. Most COVID patients were unvaccinated (94.6%) and had, on average, one comorbidity. Hypertension (19.1%), immunocompromised condition (23.8%), mental health conditions (15%), obesity (10.8%), and cancer (11.2%) were the common prevalent comorbidities. The presence of comorbidity increased the risk of severe or critical COVID-19. COVID-19 cases were associated with the lack of vaccination and comorbidities. Effective vaccination strategies are needed to reduce the burden of COVID-19 in Colombia and, considering budgetary constraints, it is advisable to prioritize the elderly or populations with underlying conditions.Keywords
Funding Information
- Pfizer
This publication has 32 references indexed in Scilit:
- Navigating the waves in Colombia: a cohort study of inpatient care during four COVID-19 wavesThe Brazilian Journal of Infectious Diseases, 2024
- COVID-19 in Latin America: A Snapshot in Time and the Road AheadInfectious Diseases and Therapy, 2023
- Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic reviewNew Microbes and New Infections, 2022
- Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral centerRespiratory Medicine, 2022
- Association of body mass index with COVID-19 related in-hospital deathClinical Nutrition, 2022
- Increased COVID-19 Infection Risk Drives Racial and Ethnic Disparities in Severe COVID-19 OutcomesJournal of Racial and Ethnic Health Disparities, 2022
- Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in JapanJournal of Infection and Chemotherapy, 2021
- SARS-CoV2/COVID-19 Infection in Transplant Recipients and in Patients on the Organ Transplant Waiting List in ColombiaTransplantation Proceedings, 2021
- COVID-19 in Colombia endpoints. Are we different, like Europe?Research in Social and Administrative Pharmacy, 2021
- Epidemiology of SARS-CoV-2Infection, 2020